HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ming-Hsien Chien Selected Research

Environmental Carcinogens

1/2018Associations of genetic variations of the endothelial nitric oxide synthase gene and environmental carcinogens with oral cancer susceptibility and development.
1/2015Interactions between environmental factors and melatonin receptor type 1A polymorphism in relation to oral cancer susceptibility and clinicopathologic development.
1/2013Combined effects of icam-1 single-nucleotide polymorphisms and environmental carcinogens on oral cancer susceptibility and clinicopathologic development.
1/2013Impact of VEGF-C gene polymorphisms and environmental factors on oral cancer susceptibility in Taiwan.
1/2012Impacts of microRNA gene polymorphisms on the susceptibility of environmental factors leading to carcinogenesis in oral cancer.
1/2012Impacts of CA9 gene polymorphisms and environmental factors on oral-cancer susceptibility and clinicopathologic characteristics in Taiwan.
1/2012Effects of NFKB1 and NFKBIA gene polymorphisms on susceptibility to environmental factors and the clinicopathologic development of oral cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ming-Hsien Chien Research Topics

Disease

85Neoplasms (Cancer)
06/2022 - 06/2008
35Neoplasm Metastasis (Metastasis)
06/2022 - 10/2010
16Squamous Cell Carcinoma of Head and Neck
01/2022 - 01/2012
15Mouth Neoplasms (Oral Cancer)
01/2022 - 10/2010
15Hepatocellular Carcinoma (Hepatoma)
05/2021 - 09/2011
11Carcinogenesis
01/2022 - 01/2012
11Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
08/2020 - 12/2009
10Pneumonia (Pneumonitis)
12/2016 - 11/2011
8Lung Neoplasms (Lung Cancer)
06/2022 - 10/2010
8Prostatic Neoplasms (Prostate Cancer)
01/2021 - 04/2014
7Adenocarcinoma of Lung
10/2021 - 05/2012
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 04/2017
6Leukemia
01/2018 - 12/2009
6Inflammation (Inflammations)
01/2016 - 10/2010
5Lymphatic Metastasis
01/2021 - 04/2012
5Carcinoma (Carcinomatosis)
02/2019 - 01/2012
4Glioblastoma (Glioblastoma Multiforme)
10/2020 - 01/2015
3Renal Cell Carcinoma (Grawitz Tumor)
04/2022 - 04/2016
3Infections
12/2018 - 12/2011
3Osteosarcoma (Osteogenic Sarcoma)
10/2018 - 02/2015
3Head and Neck Neoplasms (Head and Neck Cancer)
01/2018 - 02/2013
3Hypoxia (Hypoxemia)
10/2017 - 05/2012
3Breast Neoplasms (Breast Cancer)
02/2017 - 01/2012
3Uterine Cervical Neoplasms (Cancer of the Cervix)
02/2014 - 01/2014
2Confusion (Bewilderment)
01/2016 - 07/2013
2Acute Lung Injury
08/2014 - 04/2012
2Fibrosis (Cirrhosis)
05/2014 - 12/2013

Drug/Important Bio-Agent (IBA)

16Proteins (Proteins, Gene)FDA Link
01/2022 - 02/2011
8FlavonoidsIBA
06/2019 - 01/2015
7Environmental CarcinogensIBA
01/2018 - 01/2012
6MelatoninIBA
09/2020 - 04/2016
6Matrix Metalloproteinase 9 (Gelatinase B)IBA
10/2017 - 11/2011
6Vascular Endothelial Growth Factor CIBA
05/2014 - 06/2008
5Penfluridol (Semap)IBA
06/2022 - 01/2019
5Antipsychotic Agents (Antipsychotics)IBA
06/2022 - 01/2019
5CurcuminIBA
01/2022 - 05/2015
5Biomarkers (Surrogate Marker)IBA
04/2021 - 11/2011
5CytokinesIBA
01/2021 - 10/2010
5Matrix Metalloproteinases (MMPs)IBA
11/2020 - 05/2012
5Matrix Metalloproteinase 2 (Gelatinase A)IBA
10/2018 - 03/2012
5Reactive Oxygen Species (Oxygen Radicals)IBA
03/2018 - 05/2015
5Carbonic Anhydrase IXIBA
10/2017 - 01/2012
4Proteoglycans (Proteoglycan)IBA
01/2022 - 06/2019
4DNA (Deoxyribonucleic Acid)IBA
01/2022 - 01/2014
4Transcription Factor AP-1 (Transcription Factor AP 1)IBA
01/2022 - 01/2012
4CaspasesIBA
03/2020 - 01/2014
4Pharmaceutical PreparationsIBA
01/2019 - 01/2012
4Lipocalin-2IBA
01/2016 - 12/2012
4Anti-Bacterial Agents (Antibiotics)IBA
01/2016 - 04/2013
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2014 - 12/2009
3Glucose (Dextrose)FDA LinkGeneric
06/2022 - 01/2018
3Adenosine Triphosphate (ATP)IBA
06/2022 - 01/2019
3ErbB Receptors (EGF Receptor)IBA
10/2021 - 01/2018
3Messenger RNA (mRNA)IBA
05/2021 - 09/2014
3Histone MethyltransferasesIBA
05/2021 - 10/2010
3RNA (Ribonucleic Acid)IBA
01/2021 - 10/2017
3Long Noncoding RNAIBA
01/2021 - 02/2019
3garcinolIBA
10/2020 - 03/2014
3AcetyltransferasesIBA
01/2020 - 02/2011
3Tyrosine Kinase InhibitorsIBA
01/2020 - 01/2018
3LigandsIBA
01/2020 - 10/2010
3ApigeninIBA
06/2019 - 02/2017
3ChemokinesIBA
10/2018 - 10/2010
3JNK Mitogen-Activated Protein KinasesIBA
10/2018 - 11/2016
3norcantharidinIBA
04/2018 - 01/2012
3QuercetinIBA
10/2017 - 07/2015
3NF-kappa B (NF-kB)IBA
01/2017 - 01/2012
3Glycoproteins (Glycoprotein)IBA
01/2017 - 12/2012
3Biological ProductsIBA
12/2015 - 01/2013
3Cadherins (E-Cadherin)IBA
12/2015 - 09/2011
2Dopamine Receptors (Dopamine Receptor)IBA
04/2022 - 01/2018
2CarcinogensIBA
01/2022 - 01/2021
2Cisplatin (Platino)FDA LinkGeneric
10/2021 - 01/2014
2InterleukinsIBA
01/2021 - 04/2012
2CateninsIBA
01/2021 - 12/2018
2Tissue Inhibitor of Metalloproteinase-3IBA
10/2020 - 10/2019
2p38 Mitogen-Activated Protein KinasesIBA
08/2020 - 01/2014
2demethoxycurcuminIBA
08/2020 - 03/2020
2AndrogensIBA
01/2020 - 08/2015
2VA 061 (VA061)IBA
01/2020 - 08/2015
2Stem Cell FactorIBA
01/2019 - 12/2018
2EnzymesIBA
03/2018 - 01/2018
2Histones (Histone)IBA
01/2018 - 02/2017
2tricetinIBA
07/2017 - 01/2015
2MicroRNAs (MicroRNA)IBA
01/2017 - 01/2012
2Melatonin Receptors (Melatonin Receptor)IBA
01/2017 - 01/2015
2GlutaminaseIBA
01/2017 - 12/2016
2Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
12/2016 - 01/2013
2Urea (Carbamide)FDA LinkGeneric
01/2016 - 07/2013
2osthol (osthole)IBA
08/2015 - 05/2012
2CoumarinsIBA
08/2015 - 05/2012
2ResveratrolIBA
02/2015 - 01/2014
2Caspase 8 (Caspase-8)IBA
12/2014 - 10/2013
2Carbonic Anhydrases (Carbonic Anhydrase)IBA
09/2014 - 08/2012
2LipopolysaccharidesIBA
08/2014 - 04/2012
2Small Interfering RNA (siRNA)IBA
02/2014 - 10/2013

Therapy/Procedure

15Therapeutics
04/2022 - 03/2011
5Drug Therapy (Chemotherapy)
04/2022 - 01/2017
2Prostatectomy (Retropubic Prostatectomy)
07/2016 - 04/2014
2Transplantation
08/2014 - 04/2012